Meta description: An observational perioperative risk study assesses frailty evaluation and ASA classification differences between clinicians and AI language models, highlighting regulatory considerations for decision support tools.
On February 11, 2026 a not yet recruiting observational trial is registered at Fatih Sultan Mehmet Training and Research Hospital to study perioperative risk assessment. The trial, identified on ClinicalTrials.gov as NCT07399938, describes an observational assessment with the aim to examine how frailty measures relate to perioperative risk, and how ASA classification may align or diverge when applied by human clinicians versus AI language models. The sponsor is Fatih Sultan Mehmet Training and Research Hospital. For more information you can view the record here: ClinicalTrials.gov record NCT07399938.
In this article navigation: What changed? Who is affected? How is frailty assessed? What is the regulatory context? Next steps
What changed?
The source indicates an observational study of frailty in perioperative risk and notes that the intervention is observational only with no active therapy. The ClinicalTrials.gov record confirms a not yet recruiting status and the sponsor details. The title pointing to a comparison between clinicians and an AI language model suggests a cognitive difference in how frailty signals are interpreted. Regulators may see this as a prompt to clarify how new tools could influence ASA style classification and patient risk estimates.
Who is affected?
Perioperative teams including surgeons, anesthesiologists, nurses, and risk management staff may be affected by how frailty signals are interpreted in ASA style risk stratification. Regulators and trial sponsors will monitor how results are reported and whether AI assistance could be introduced as a decision support tool in the future. Not yet recruiting status means results are pending and further guidance may follow.
How is frailty assessed and ASA classification applied?
The study uses an observational assessment approach and does not include an intervention. Frailty indicators are examined in relation to perioperative risk reasoning, and there is a noted comparison to ASA classification. If AI language models are used to assist with classification in the future, validation and documentation of intended use will be essential under medical device regulations. The ClinicalTrials.gov entry provides a reference point for investigators and regulators to track development.
What is the regulatory context for these findings?
From a medical device regulation perspective the article emphasizes intended use, performance, and safety when AI based decision support is involved. MDR Annex XIV style language informs practitioners about the required clarity of intended purpose and safety concerns. The current source describes an observational effort and does not claim device performance, but the possibility of AI assisted ASA classification highlights the need for governance and transparent data practices.
What are the next steps for researchers and regulators?
Researchers should plan follow up studies with larger samples and robust validation of frailty measures against ASA style classification. Regulators may issue guidance on data governance, validation procedures, and reporting standards for AI driven decision support used in perioperative risk. Sponsors will publish enrollment updates and any early insights, while clinical teams await clarified use cases that align with safety and regulatory requirements.
- Q1 What is the source for this article? The information comes from the ClinicalTrials.gov record NCT07399938 and the sponsor description as well as a title that suggests a comparison between clinicians and an AI language model in frailty based ASA classification.
- Q2 Is this a device trial? The source describes an observational assessment with no active intervention and status not yet recruiting. It does not report device performance at this time.
- Q3 When will results be available? The source does not provide results yet; status is not yet recruiting and updates would come from the study investigators or sponsor.
https://clinicaltrials.gov/study/NCT07399938?term=medical+device